Skip to content
PICO Portalanswers from OpenAlex

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

PaperCitations, authors & open-access status

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection is a paper indexed in PICO Portal from OpenAlex.

How many citations does Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection have?

PICO Portalcitation count

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection has 217 citations in the OpenAlex counts PICO Portal stores.

When was Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection published?

PICO Portalyear

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection has 2020 year in the PICO Portal index.

What is the open-access status of Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection?

PICO Portaloa status

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection has hybrid oa status in the PICO Portal index.

What is the DOI of Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection?

PICO Portaldoi

The DOI for Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection is on the source record.

What is the PMID of Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection?

PICO Portalpmid

The PMID for Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection is on the source record.

What is the OpenAlex record for Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection?

PICO Portalopenalex

The OpenAlex for Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial